This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pollick, C. Articles by Wigle, E. D. Search for Related Content PubMed PubMed Citation Articles by Pollick, C. Articles by Wigle, E. D.

Circulation, Vol 69, 43-49, Copyright © 1984 by American Heart Association

ARTICLES

Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient

C Pollick, H Rakowski and ED Wigle

We performed simultaneous echocardiographic and hemodynamic studies in 11 patients with muscular subaortic stenosis to determine whether systolic anterior motion (SAM) of the anterior mitral leaflet and the pressure gradient are related quantitatively. SAM without septal contact was associated with either no gradient or a small impulse gradient of less than 10 mm Hg. SAM with septal contact was always associated with a pressure gradient of more than 10 mm Hg. The size of the pressure gradient correlated inversely with the time periods: (1) onset of SAM-septal contact (r = .79, p less than .001) and (2) onset of aortic ejection to onset of SAM-septal contact (r = -.89, p less than .001). Size also correlated directly with the time period: (3) duration of SAM-septal contact (r = .80, p less than .001). Thus when the time from the onset of SAM to the onset of SAM-septal contact was long, SAM-septal contact developed late in systole, the duration of SAM- septal contact was brief and the pressure gradient was low. When SAM- septal contact developed in early systole, the duration of SAM-septal contact was long and the pressure gradient was high. With the index of time period (3) divided by time period (1), a regression equation was devised to predict the size of the pressure gradient (pressure gradient [mm Hg] = 25 [ratio] + 25; r = .90, p less than .001; SE +/- 15 mm Hg). The echocardiographic time period index was validated prospectively in nine other patients and the significant correlation with the hemodynamically determined gradient persisted (r = .89, p less than .01). We conclude that SAM and the pressure gradient are related quantitatively in muscular subaortic stenosis. These observations have implications regarding the mechanism and significance of the pressure gradient in muscular subaortic stenosis.

This article has been cited by other articles:

				D H Kwon, N G Smedira, Z B Popovic, B W Lytle, R M Setser, M Thamilarasan, P Schoenhagen, S D Flamm, H M Lever, and M Y Desai Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging Heart, November 1, 2009; 95(21): 1784 - 1791. [Abstract] [Full Text] [PDF]

				B. J. Maron, M. S. Maron, E. D. Wigle, and E. Braunwald The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 191 - 200. [Abstract] [Full Text] [PDF]

				D. H. Kwon, N. G. Smedira, E. R. Rodriguez, C. Tan, R. Setser, M. Thamilarasan, B. W. Lytle, H. M. Lever, and M. Y. Desai Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 242 - 249. [Abstract] [Full Text] [PDF]

				D H Kwon, R M Setser, M Thamilarasan, Z V Popovic, N G Smedira, P Schoenhagen, M J Garcia, H M Lever, and M Y Desai Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart, October 1, 2008; 94(10): 1295 - 1301. [Abstract] [Full Text] [PDF]

				B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF]

				Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				L Faber, A Meissner, P Ziemssen, and H Seggewiss Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients Heart, March 1, 2000; 83(3): 326 - 331. [Abstract] [Full Text]

				P. Spirito, C. Rapezzi, P. Bellone, S. Betocchi, C. Autore, M. R. Conte, G. P. Bezante, and P. Bruzzi Infective Endocarditis in Hypertrophic Cardiomyopathy : Prevalence, Incidence, and Indications for Antibiotic Prophylaxis Circulation, April 27, 1999; 99(16): 2132 - 2137. [Abstract] [Full Text] [PDF]

				D. Pavin, C. de Place, H. Le Breton, C. Leclercq, D. Gras, F. Victor, P. Mabo, and J.-C. Daubert Effects of permanent dual-chamber pacing on mitral regurgitation in hypertrophic obstructive cardiomyopathy Eur. Heart J., February 1, 1999; 20(3): 203 - 210. [Abstract] [PDF]

				L. Faber, H. Seggewiss, and U. Gleichmann Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy : Results With Respect to Intraprocedural Myocardial Contrast Echocardiography Circulation, December 1, 1998; 98(22): 2415 - 2421. [Abstract] [Full Text] [PDF]

				E. Schwammenthal, S. Nakatani, S. He, J. Hopmeyer, A. Sagie, A. E. Weyman, H. M. Lever, A. P. Yoganathan, J. D. Thomas, and R. A. Levine Mechanism of Mitral Regurgitation in Hypertrophic Cardiomyopathy : Mismatch of Posterior to Anterior Leaflet Length and Mobility Circulation, September 1, 1998; 98(9): 856 - 865. [Abstract] [Full Text] [PDF]

				A. M. Kizilbash, S. K. Heinle, and P. A. Grayburn Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy Circulation, February 10, 1998; 97(5): 461 - 466. [Abstract] [Full Text] [PDF]

				M. V. Sherrid, G. Pearle, and D. Z. Gunsburg Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy Circulation, January 13, 1998; 97(1): 41 - 47. [Abstract] [Full Text] [PDF]

				M. Hamada, Y. Shigematsu, S. Ikeda, Y. Hara, H. Okayama, K. Kodama, T. Ochi, and K. Hiwada Class Ia Antiarrhythmic Drug Cibenzoline : A New Approach to the Medical Treatment of Hypertrophic Obstructive Cardiomyopathy Circulation, September 2, 1997; 96(5): 1520 - 1524. [Abstract] [Full Text]

				D. F. Vitale, R. O. Bonow, R. Calabro, M. De Cristofaro, G. Pacileo, P. Caso, G. Gerundo, C. Bordini, M. A. Losi, C. Rengo, et al. Myocardial Ultrasonic Tissue Characterization in Pediatric and Adult Patients With Hypertrophic Cardiomyopathy Circulation, December 1, 1996; 94(11): 2826 - 2830. [Abstract] [Full Text]

				J. Bartunek, S. U. Sys, A. C. Rodrigues, E. Van Schuerbeeck, L. Mortier, and B. de Bruyne Abnormal Systolic Intraventricular Flow Velocities After Valve Replacement for Aortic Stenosis : Mechanisms, Predictive Factors, and Prognostic Significance Circulation, February 15, 1996; 93(4): 712 - 719. [Abstract] [Full Text]

				E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text]

				R. A. Levine, G. J. Vlahakes, X. Lefebvre, J. L. Guerrero, E. G. Cape, A. P. Yoganathan, and A. E. Weyman Papillary Muscle Displacement Causes Systolic Anterior Motion of the Mitral Valve : Experimental Validation and Insights Into the Mechanism of Subaortic Obstruction Circulation, February 15, 1995; 91(4): 1189 - 1195. [Abstract] [Full Text]

				E. K. LOUIE and B. J. MARON Apical Hypertrophic Cardiomyopathy: Clinical and Two-Dimensional Echocardiographic Assessment Ann Intern Med, May 1, 1987; 106(5): 663 - 670. [Abstract] [PDF]